iHealthScreen (Equity)

Funding Details
Awarder
StartEngine
Date Award
August 01, 2023
Vertical
AI-Driven Disease Screening Software
Funding URL
View Funding Page
Premoney Valuation
$24,980,000,000,000
Valuation
$24,980,000,000,000

Company Info
Founding Year
2017
Traction
iHealthScreen has received $2.7M in NIH funding, raised $750K as seed funding, and has established partnerships with key industry players. The company has achieved CE certification for AMD, DR, and glaucoma screening and is developing prediction models for strokes, heart attacks, and cardiovascular diseases.
Organizations Involved
NIH, iCare, Bangladesh Diabetes Society, Burjeel Hospital UAE
Founders
Alauddin Bhuiyan
Company Description
iHealthScreen is an AI-driven HIPAA-compliant med-tech company specializing in Scalably Screening for Retinal Diseases, Stroke, and Heart Disease using AI technology. The company aims to prevent blindness, save lives, and reduce downstream healthcare costs through early diagnosis and intervention. iHealthScreen is in the pre-revenue stage of development.
Market
Healthcare
Location
Richmond Hill, NY, US
Coinvestors
StartEngine Capital, LLC

Links
Back to Home Back to AI-Driven Disease Screening Software Deals View Funding Announcement